NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma.
Respir Res. 2020 Oct 13;21(1):266. doi: 10.1186/s12931-020-01526-6.
Respir Res. 2020.
PMID: 33050934
Free PMC article.
Clinical Trial.